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The key experiment described here showed that a eukaryotic transcriptional 
activator is a modular protein composed of a DNA-binding domain and an 
"activating region" (2466). The definition of these as distinct, separable 
elements led to a coherent picture for how such activators work; provided a 
powerful tool for the analysis of other gene-activating and - repressing functions; 
laid the basis for the development of the two-hybrid system for detecting 
protein-protein interactions; and now provides a framework for understanding 
how specificity is achieved in many cellular information processing networks. 
Background 
The key experiment we shall describe was performed in yeast, a simple 
eukaryote. Our understanding of gene regulation in bacteria around 1985 
strongly influenced the design of the experiment. By that time, we had in hand 
three concepts describing how a bacterial regulatory protein could recognize a 
specific sequence in DNA (called an operator) and activate or repress 
transcription of a gene. We begin here with a brief statement of these three 
concepts, as exemplified by the action of lambda repressor, the protein we were 
studying most intensively (see EXP, Isolation of repressor
†
): 
• A regulatory protein (repressor or activator) binds a specific sequence in DNA 
without significantly changing the structure of either the protein or the DNA. 
• A repressor turns off (represses) a gene by excluding RNA polymerase from 
that gene. This effect requires that an operator site overlap the binding site for 
RNA polymerase (the promoter). 
• An activator turns on (activates) transcription of a gene that bears an operator 
site immediately adjacent to the promoter. Activation is effected by a protein- 
protein interaction between the regulator and RNA polymerase, an interaction 
that we now know recruits RNA polymerase to the gene. Specific amino acids 
on a surface of the activator, distinct from the DNA interaction surface, are re- 
quired for the interaction with RNA polymerase. 
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Figure 1 illustrates the third concept, the activation of transcription by lambda re- 
pressor. 
 
Figure 1 Activation by a prokaryotic protein. 
The amino terminus of a lambda repressor 
dimer bound to the operator site OR2 re- 
cruits (binds cooperatively to DNA with) RNA 
polymerase. The polymerase transcribes the 
repressor gene (cI), and thus repressor stim- 
ulates transcription of its own gene. The 
polymerase site contacted by repressor, we 
now know, is in its sigma70 subunit. 
 
 
 
 
 
In the mid-1980s, we began to wonder whether this picture from bacteria applied 
in eukaryotes as well. There were good grounds for thinking it might not. For ex- 
ample, unlike in bacteria, DNA in eukaryotes is wrapped around histone proteins 
to form nucleosomes, and the DNA is sequestered in a special compartment, the 
nucleus. Moreover, unlike in the lambda case, eukaryotic regulators often exert 
their effects over many hundreds, or even thousands, of base pairs. As we shall 
see, however, the lessons from bacteria stood us in good stead, and taken together 
with the studies from yeast we now describe, provided a unified view of many as- 
pects of gene regulation, applying to both bacteria and eukaryotes. (2472, 
2481, 2471, 3048, 100) 
The Yeast Transcriptional Activator Gal4 In the early 1980s, we and others had 
begun analysis of gene activation in a simple eukaryote, the yeast S. cerevisiae. 
Genetic studies had shown that the Gal4 protein is required for transcription of 
various Gal genes, the products of which metabolize the sugar galactose. (See, for 
example, 2480.) Addition of galactose to the medium induced transcription of the 
various GAL genes well over a thousand fold. This feature, taken with the 
ease with which experiments could be done with yeast, encouraged us to study 
gene activation by Gal4. 
Our first important finding was that Gal4 is indeed a specific DNA-binding pro- 
tein. Guarente and coworkers had shown that a fragment of about 100 base pairs, 
if positioned some 250 base pairs upstream of the GAL1 gene, was sufficient to 
confer galactose regulation on another promoter, that of the gene CYC1 
(2471). They termed the site of Gal4 action the Galactose Upstream Activating 
Sequence, or UASG. 
Using in vivo footprinting techniques and deletion analysis, we found that Gal4 
bound specifically to repeated 17-base-pair sequences in UASG (2497, 2498, 
2468). At the time, we did not know how Gal4 recognized DNA. The symmetry 
of each of the sites suggested that the protein bound as a dimer, but the Gal4 pro- 
tein sequence did not bear the helix-turn-helix motif characteristic of the bacterial 
DNA-binding regulators known at that time. This contributed to our concern that 
protein binding to DNA in a eukaryotic nucleus, where it is wrapped in nucleo- 
somes, might require some still undescribed mechanism. The following prelimi- 
nary yeast experiment shows that this concern was unfounded. 
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Setting the Stage: Repression by a Bacterial Protein in Yeast 
 
This preliminary experiment was performed with a bacterial repressor called 
LexA. We and others had shown that LexA binds to well-defined DNA sites, a 
dimer of the protein rec- ognizing each site (2464, 2479, 2475). Our knowledge 
was consistent with the idea that DNA-bound LexA works as do other 
repressors: it turns off transcrip- tion of a gene by competing for binding of 
polymerase to an overlapping pro- moter. We knew that LexA comprised 
two domains connected by a flexible linker: an amino terminal domain that 
contained the DNA-binding function, and a carboxyl terminal domain that 
contained a dimerization function. Sequence com- parison indicated that LexA 
recognized DNA using a helix-turn-helix motif simi- lar to that found in lambda 
repressor. Unlike lambda repressor, there was no evi- dence that LexA activated 
transcription in prokaryotes; as we now understand, it lacks an activating region. 
We placed LexA binding sites between the Gal4 binding sites (UASG) and the 
start site of transcription of a yeast reporter. We introduced these constructs into 
yeast along with a second construct (now called an effector construct) expressing 
the LexA gene under the control of a yeast promoter. LexA repressed 
transcription from some of these constructs. That is, we found certain 
positions for the LexA sites at which repression occurred, but others also 
between the UASG and the gene, at which LexA had no effect (2465). 
The results showed that, in yeast, LexA bound its operator sites. Thus, this bacte- 
rial protein entered a eukaryotic nucleus and bound its operator sites despite 
DNA's presumably being wrapped in nucleosomes. The results also argued 
against so-called "transmission" models for activation by Gal4. According to such 
models, the activator transmitted some signal (for example, to unwind the DNA) 
through or along the DNA. Those models predicted that the repressive effects of 
LexA would not depend on the exact positioning of the LexA bound between the 
UASG and the gene. 
The Key Experiment: The Domain Swap 
We thus began with two proteins that bound different DNA sites in yeast. One, 
the yeast activator Gal4, activated transcription; the other, the bacterial repressor 
LexA, did not. In bacteria, lambda repressor binds immediately adjacent to the 
gene it activates, whereas in yeast, Gal4 typically binds some 250 base pairs 
away. We nevertheless imagined that the role of DNA binding might be the 
same in both cases, namely, to position the activator near the gene. In that case, 
we might be able to replace the Gal4 DNA- binding domain with that of LexA 
and activate transcription of a gene with LexA binding sites nearby. 
We constructed and expressed in yeast a chimeric protein, LexA-Gal4. The 
fusion carried the DNA-binding region of LexA (residues 1-87) fused to a 
C- terminal portion of Gal4 (residues 74-881) that contained more than 90 
percent of the Gal4 coding sequence. 
The key result is shown in Figure 2.  When LexA-Gal4 was expressed in yeast, it 
activated transcription of a reporter gene near which we had placed LexA DNA- 
binding sites. LexA-Gal4 did not activate if the gene lacked LexA binding sites, 
even if it carried a Gal4 binding site (a "17-mer"). 
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Figure 2 Activation by LexA and 
LexA-Gal4. The figure shows 
transcription measured by ex- 
pression of a gal1-lacZ reporter 
gene. LexA-Gal4 stimulates tran- 
scription of a gene that carries a 
LexA operator, but not of a gene 
that carries a Gal4-binding site. 
Numbers    denote    units    of    - 
galactosidase activity. (This fig- 
ure is adapted from Table 3 of 
Brent and Ptashne, 1985.) 
 
 
 
 
 
 
 
 
This experiment, whose findings are illustrated in Figure 3, showed the follow- 
ing: 
 
 
Figure 3 The domain swap experi- 
ment summarized: separation of 
DNA-binding and -activating re- 
gions. LexA-Gal4 binds LexA oper- 
ators and activates transcription, 
LexA binds LexA operators, and 
Gal4 (1–147) binds Gal4 sites. 
None of them, however, activate 
trancription because none bear an 
activating region such as that con- 
tained in the carboxyl part of Gal4. 
 
 
 
 
 
 
 
 
 
 
• Gal4 contains an "activating region" that can be transferred, without loss of 
function, to a heterologous DNA-binding domain. 
• No special mode of DNA binding is required for activation in eukaryotes be- 
yond that found in a bacterial repressor. 
• Specificity of an activator is determined by its DNA-binding address: Gal4 
works if a gene bears a Gal4 binding site, and LexA-Gal4 works if a gene bears 
a LexA site. The role of DNA binding is to tether the activating region near the 
gene to be activated. 
• The activating region itself does not activate unless tethered to DNA. 
• Eukaryotic transcriptional activators are modular proteins, surprisingly easily 
separated into different functional bits. 
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• The amino portion of Gal4 (missing from the LexA-Gal4 fusion) bears the 
Gal4 DNA binding domain. A Gal4 fragment bearing that domain (e.g., Gal4 
[1-147] binds Gal4 sites in yeast but does not activate transcription because it 
lacks an activating region [2474]). This Gal4 fragment is analogous to the so- 
called "positive control" (pc) mutants of lambda repressor. Those mutants, 
which bear amino acid changes on the surface of repressor that contacts RNA 
polymerase, bind DNA normally but do not activate transcription (2479). 
 
Serendipity  
Before touching upon some subsequent developments, we point out three bits 
of good fortune that allowed the success of the LexA-Gal4 domain swap 
experiment. 
LexA turned out to be a good DNA-binding domain in eukaryotes. For unknown 
reasons (possibly small differences in protein level and/or operator affinity), 
lambda repressor, the protein we had studied most intensively, did not work in 
the initial yeast experiments. Had we not been studying LexA in previous years, 
we would not have had a prokaryotic DNA domain that we knew bound DNA in 
yeast. 
The LexA fragment that was used to make LexA-Gal4 lacked the C-terminal 
dimerization domain required for efficient DNA binding of LexA. We believed 
that Gal4 also bound DNA as a dimer and, in those days before the widespread 
use of synthetic DNA, took advantage of a well-placed restriction site to generate 
a very large C-terminal fragment of Gal4 fused to the amino part of LexA. 
Luckily, that carboxyl Gal4 fragment supplied, in addition to an activating 
region, a dimerization function, but just barely: we now know that the first Gal4 
residue in LexA-Gal4 is the first residue of the dimerization region. The ability 
of the Gal4 dimerization region to effect dimerization (and hence efficient DNA 
binding) of the LexA DNA binding domain defines another modular, 
swappable, functional element. 
We subsequently learned that LexA and LexA-Gal4 lacked nuclear localization 
sequences and were not concentrated in the nucleus (2477). Both proteins were 
functional (even the >90-kiloDalton LexA-Gal4), which showed that such signals 
were not always required for nuclear entry, contrary to what we had believed up 
to that time. 
Some Subsequent Developments 
There were previous examples of protein modularity (for example, the DNA-
binding and dimerization domains of lambda repressor). However, the domain 
swap experiment and the continuing flood of experiments to construct new 
multifunctional chimeric proteins vividly illustrate just how widespread is the 
modular principle of protein design. 
Gal4, we soon learned, is a "universal" activator: it will work in any eukaryote, 
provided the test gene is modified by the introduction of Gal4 binding sites 
nearby and Gal4 is artificially expressed in that organism (2473, 2478). Gal4 is 
widely used to activate specific genes in specific tissues (e.g., in Drosophila; see 
2499). Chimeras that contain other universal activation regions are used to turn 
genes on and off in response to treatment, for example, with tetracycline (2469). 
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Universal activating regions typically bear an excess of acidic residues, plus 
crucial hydrophobic residues. One can readily detect activating regions by 
fusing candidates to a DNA-binding domain, expressing the hybrid proteins, and 
assaying for activation of a reporter gene. 
Tethering the activating region to the promoter does not require that the 
activating region be covalently linked to the DNA-binding domain. Bringing the 
activating region to DNA by a protein-protein interaction triggers activation 
of transcription. Consider, for example, the protein Gal80, which inhibits Gal4 
by binding to and covering Gal4's activating region. Fusion of an activating 
region con- verts Gal80 to an activator when it binds to DNA-bound Gal4 
(2476). Noting this, Fields and Song developed the two-hybrid system (952). 
That system detects interaction between proteins, one fused to a DNA-binding 
domain and the other fused to an activating region, by activation of transcription. 
Transcription by tethered activating regions (as in the two-hybrid system) is now 
used to map interactions among the protein complements of entire genomes. 
Several lines of evidence show that the typical eukaryotic transcriptional 
activating region works by recruiting the transcriptional machinery to a 
nearby promoter. One finding consistent with this idea was that, when 
expressed in large amounts and not tethered to DNA, free activating regions 
squelched transcription (2467). The properties of activating regions also accord 
with this surmise. In particular, studies showing eukaryotic activating regions to 
be flexible in both size and sequence helped spell the end of the idea that the 
activation function might involve an enzymatic activity. Various lines of 
evidence suggest that these activating regions can touch an array of targets in 
the very complicated transcriptional machinery of eukaryotes (over fifty 
proteins), recruiting whatever is necessary to ensure transcription of a given 
gene. According to this general picture, the typical eukaryotic activator works 
by the same fundamental mechanism as does lambda repressor working as an 
activator: at the heart of each process lies cooperative binding to DNA of 
activator and target, a process that recruits the transcription machinery to the 
promoter. 
The Legacy 
Classical biochemistry taught us that substrate recognition by enzymes (those 
involved in intermediary metabolism, for example) was determined by highly 
specific interactions governed by the precise geometries of the interacting 
moieties. Each such enzyme typically recognizes one and only one substrate, 
usually a small molecule. Now we see that many enzymes, particularly those 
involved in regulatory processes, share a property with RNA polymerase: 
their specificities are not determined solely by their active sites. Rather, just as 
RNA polymerase has many possible genes it might work on, so too does the 
typical kinase, phosphatase, protease, etc., have many possible substrates. 
Which one is chosen, the regulatory choice, is determined in many cases by the 
kinds of mechanisms we describe here for transcriptional activation. 
For example, modular regulatory proteins involved in proteolysis (e.g., F box 
proteins) direct a ubiquitylating enzyme to specific substrates by binding the 
enzyme to one surface, and the specific substrates to another. This strategy, 
imposing specificity on enzyme action by recruitment, figures prominently in the 
workings of the intracellular pathways that the cell uses to transmit and process 
information (2500). 
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